AstraZeneca and the Hungarian Nephrological Society enter into strategic cooperation
It is estimated that nearly 850 million people worldwide suffer from impaired kidney function and its complications, and all indications are that this will be one of the most threatening diseases in the future. In our country, about one and a half million people can be affected by chronic kidney disease, while depending on their progression, it can increase the risk of cardiovascular damage by up to 14 times.
Related news
Uk medicines authority registers AstraZeneca’s COVID-19 antibody Evusheld
AstraZeneca’s Evusheld has been approved for use by the Medicines…
Read more >U.S. Drug Administration approves long-acting antibody AstraZeneca Evusheld (AZD7442)
AstraZeneca’s Evusheld is a long-acting combination of antibodies (tixagevimab and…
Read more >Related news
Holiday Shopping Study 2024: European Consumers Plan Ahead Amid Economic Pressures
The “Holiday Shopping Study 2024,” conducted by ShopFully and Offerista…
Read more >Oversupply in the office market, returning demand in retail properties and hotels expected in 2025
The Hungarian commercial real estate market is currently characterized by…
Read more >Sándor Czomba: the minimum wage will increase by nine percent next year
The minimum wage will increase by nine percent next year,…
Read more >